Current Value
$31.181 Year Return
Current Value
$31.181 Year Return
Double maintains 5 strategies that include QDEL - QuidelOrtho Corp.
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
ECPG | 60.77% | $960.35M | -8.01% | 0.00% |
VYX | 55.04% | $1.86B | -5.53% | 0.00% |
XRAY | 54.61% | $3.31B | -35.36% | 3.89% |
FA | 54.33% | $3.06B | +10.96% | 0.00% |
MMS | 52.65% | $4.10B | -16.66% | 1.67% |
XPER | 51.87% | $364.13M | -3.39% | 0.00% |
WTS | 50.08% | $8.62B | +39.00% | 0.71% |
TECH | 49.52% | $8.53B | -28.75% | 0.60% |
BIO | 49.48% | $7.07B | -12.06% | 0.00% |
TGLS | 49.31% | $3.61B | +43.08% | 0.74% |
AZTA | 49.13% | $1.56B | -35.35% | 0.00% |
STKL | 48.67% | $761.67M | +17.39% | 0.00% |
FSLY | 47.83% | $1.00B | -7.35% | 0.00% |
LZ | 47.78% | $1.66B | +54.12% | 0.00% |
SPB | 47.75% | $1.41B | -30.95% | 3.21% |
DAY | 47.67% | $9.32B | +14.17% | 0.00% |
DHR | 47.42% | $147.08B | -16.55% | 0.57% |
RVTY | 47.31% | $12.07B | -6.76% | 0.28% |
CXT | 47.00% | $3.40B | +4.00% | 1.12% |
IQV | 46.97% | $28.64B | -24.57% | 0.00% |
Yahoo
A number of stocks fell in the afternoon session after the U.S. administration announced a sharp escalation in trade tensions by threatening new tariffs on Canada.
Yahoo
Wrapping up Q1 earnings, we look at the numbers and key takeaways for the medical devices & supplies - imaging, diagnostics stocks, including QuidelOrtho (NASDAQ:QDEL) and its peers.
Yahoo
QuidelOrtho’s first quarter results received a strong positive reaction from the market, driven by better-than-expected profitability and stable core business performance despite a year-over-year revenue decline. Management attributed the quarter’s momentum to cost-saving initiatives and robust growth in its labs and immunohematology businesses. CEO Brian Blaser highlighted that, excluding COVID and donor screening, the company achieved mid-single-digit revenue growth, largely due to strong clin
Yahoo
QuidelOrtho Corporation (Nasdaq: QDEL) (the "Company" or "QuidelOrtho"), a global provider of innovative in vitro diagnostic technologies designed for point-of-care settings, clinical labs and transfusion medicine, has appointed two industry-leading executives to its leadership team. Devon Burek joins the Company as Senior Vice President of Global Quality, and Sergio Gadaleta joins as Senior Vice President of Clinical and Regulatory Affairs. These hires reflect the Company's continued investment
Finnhub
QuidelOrtho Corporation appointed two industry-leading executives to its leadership team. Devon Burek joins the Company as Senior Vice President of Global Quality, and Sergio Gadaleta joins as Senior...
Finnhub
QuidelOrtho Corporation dropped from Russell Midcap Value Index...
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
ISTB | 0.01% | $4.41B | 0.06% |
BIL | 0.07% | $41.93B | 0.1356% |
IAGG | -0.26% | $10.49B | 0.07% |
GBIL | -0.41% | $6.36B | 0.12% |
GOVT | 0.46% | $27.25B | 0.05% |
BILZ | 0.56% | $851.85M | 0.14% |
BNDW | 0.57% | $1.28B | 0.05% |
TBIL | -0.68% | $5.76B | 0.15% |
LMBS | 0.69% | $5.11B | 0.64% |
GVI | -0.75% | $3.44B | 0.2% |
IBTP | -0.76% | $142.98M | 0.07% |
FLGV | 1.13% | $1.02B | 0.09% |
BUXX | -1.24% | $312.40M | 0.25% |
CORN | -1.26% | $43.71M | 0.2% |
BOXX | 1.40% | $6.93B | 0.19% |
BSMW | -1.42% | $107.49M | 0.18% |
BSCP | -1.43% | $3.25B | 0.1% |
JPLD | 1.44% | $2.06B | 0.24% |
GLTR | 1.57% | $1.45B | 0.6% |
TIPX | 1.64% | $1.73B | 0.15% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CODI | -41.03% | $495.81M | -70.87% | 15.44% |
COR | -22.02% | $57.63B | +33.93% | 0.73% |
MUSA | -18.80% | $8.44B | -9.52% | 0.45% |
CBOE | -17.37% | $24.55B | +38.09% | 1.08% |
MCK | -15.85% | $89.25B | +24.22% | 0.40% |
TSE | -12.24% | $110.16M | +21.65% | 1.31% |
FSM | -11.03% | $2.04B | +23.33% | 0.00% |
HRB | -9.97% | $7.60B | +6.69% | 2.63% |
CME | -9.60% | $99.17B | +44.04% | 1.75% |
ED | -9.48% | $36.42B | +10.51% | 3.36% |
LITB | -8.21% | $24.26M | -71.62% | 0.00% |
EXC | -8.20% | $44.05B | +23.53% | 3.60% |
AG | -7.67% | $4.19B | +29.73% | 0.22% |
SAND | -6.80% | $2.88B | +70.54% | 0.58% |
BTI | -6.06% | $111.18B | +57.68% | 6.01% |
PHYS | -6.01% | - | - | 0.00% |
MSIF | -5.91% | $773.71M | +36.92% | 7.56% |
WMK | -5.86% | $2.01B | +12.45% | 1.82% |
CNR | -5.69% | $3.81B | -28.11% | 0.98% |
KGC | -5.42% | $18.82B | +67.10% | 0.78% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
LILAK | -0.01% | $1.28B | -34.92% | 0.00% |
ARGX | -0.04% | $34.47B | +22.00% | 0.00% |
DFDV | -0.05% | $363.21M | +2,422.23% | 0.00% |
HUSA | -0.05% | $20.99M | -8.33% | 0.00% |
PRPO | -0.21% | $23.73M | +229.04% | 0.00% |
UL | -0.22% | $150.82B | +8.55% | 3.19% |
AEP | 0.24% | $56.65B | +16.73% | 3.49% |
HNRG | 0.30% | $680.74M | +95.07% | 0.00% |
FMX | 0.32% | $20.90B | -11.12% | 4.42% |
TK | -0.35% | $650.10M | +23.51% | 0.00% |
PULM | -0.38% | $23.52M | +206.67% | 0.00% |
LNW | -0.44% | $8.52B | -5.45% | 0.00% |
WPM | 0.54% | $40.80B | +51.61% | 0.71% |
MKTX | 0.55% | $8.21B | +2.36% | 1.37% |
KO | -0.55% | $300.31B | +10.57% | 2.87% |
SAR | -0.56% | - | - | 13.10% |
TRP | 0.56% | $49.12B | +33.66% | 5.29% |
DG | 0.58% | $24.71B | -14.69% | 2.10% |
LILA | 0.61% | $1.25B | -36.09% | 0.00% |
TNK | -0.63% | $1.53B | -29.16% | 2.27% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
XHE | 56.84% | $166.47M | 0.35% |
MOAT | 51.24% | $12.88B | 0.47% |
PRNT | 51.08% | $77.79M | 0.66% |
FXH | 49.47% | $891.22M | 0.62% |
ARKG | 49.32% | $1.03B | 0.75% |
VIOV | 49.24% | $1.31B | 0.1% |
RSPH | 49.09% | $721.17M | 0.4% |
GNOM | 49.01% | $46.47M | 0.5% |
SMOT | 48.99% | $400.13M | 0.49% |
IJS | 48.57% | $6.26B | 0.18% |
SLYV | 48.42% | $3.78B | 0.15% |
FBT | 47.71% | $1.02B | 0.54% |
RDTE | 47.69% | $139.04M | 0.97% |
PRFZ | 47.17% | $2.41B | 0.34% |
SCHA | 47.04% | $17.61B | 0.04% |
VB | 46.98% | $64.61B | 0.05% |
RZV | 46.94% | $213.28M | 0.35% |
KJUL | 46.86% | $159.39M | 0.79% |
NUSC | 46.78% | $1.16B | 0.31% |
VBK | 46.76% | $19.19B | 0.07% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
TAIL | -36.10% | $94.86M | 0.59% |
VIXY | -33.91% | $184.73M | 0.85% |
BTAL | -32.86% | $315.93M | 1.43% |
IVOL | -29.34% | $342.69M | 1.02% |
FXY | -17.87% | $802.69M | 0.4% |
FTSD | -17.35% | $233.11M | 0.25% |
XONE | -15.37% | $628.85M | 0.03% |
ULST | -14.14% | $592.38M | 0.2% |
VGSH | -14.00% | $22.68B | 0.03% |
STOT | -13.94% | $252.82M | 0.45% |
UTWO | -13.90% | $376.33M | 0.15% |
SPTS | -13.70% | $5.77B | 0.03% |
SCHO | -13.52% | $10.98B | 0.03% |
FXE | -13.11% | $588.06M | 0.4% |
LDUR | -12.83% | $922.12M | 0.5% |
UDN | -12.79% | $147.46M | 0.78% |
IBTH | -12.70% | $1.62B | 0.07% |
BWX | -12.66% | $1.53B | 0.35% |
SHYM | -11.87% | $355.86M | 0.35% |
CLIP | -10.27% | $1.55B | 0.07% |